Literature DB >> 7995399

Pulmonary macrophages.

M L Lohmann-Matthes1, C Steinmüller, G Franke-Ullmann.   

Abstract

Interest in pulmonary macrophage research has greatly increased as is now possible not only to work with the easily accessible alveolar macrophages but also with macrophages prepared from lung tissue, such as the interstitial macrophages, dendritic cells and intravascular macrophages. A fascinating aspect is that, in one organ, the modulation of macrophage functions according to their anatomical localization can be studied. This article tries to review some of the modern aspects of research on pulmonary macrophages. These include localization and origin of the various subpopulations, membrane receptors and surface markers, arachidonic acid metabolism, antimicrobial activity, cytokine production and some aspects of macrophage involvement in sarcoidosis and idiopathic lung fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995399

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  73 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Authors:  Hongwei Zhou; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

3.  Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis.

Authors:  Ping Ren; Ivan O Rosas; Sandra D Macdonald; Hai-Ping Wu; Eric M Billings; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

4.  The involvement of GM-CSF deficiencies in parallel pathways of pulmonary alveolar proteinosis and the alcoholic lung.

Authors:  William S Slovinsky; Freddy Romero; Dominic Sales; Hoora Shaghaghi; Ross Summer
Journal:  Alcohol       Date:  2018-07-18       Impact factor: 2.405

5.  Cowpox virus induces interleukin-10 both in vitro and in vivo.

Authors:  April H Spesock; Brice E Barefoot; Caroline A Ray; Daniel J Kenan; Michael D Gunn; Elizabeth A Ramsburg; David J Pickup
Journal:  Virology       Date:  2011-06-11       Impact factor: 3.616

6.  Prostaglandins D2 and E2 have opposite effects on alveolar macrophages infected with Histoplasma capsulatum.

Authors:  Priscilla A T Pereira; Patrícia A Assis; Morgana K B Prado; Simone G Ramos; David M Aronoff; Francisco W G de Paula-Silva; Carlos A Sorgi; Lúcia H Faccioli
Journal:  J Lipid Res       Date:  2017-12-07       Impact factor: 5.922

7.  CD14 expression and binding of lipopolysaccharide to alveolar macrophages and monocytes.

Authors:  T S Haugen; B Nakstad; O H Skjønsberg; T Lyberg
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

8.  Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages.

Authors:  Jessica Hoppstädter; Britta Diesel; Robert Zarbock; Tanja Breinig; Dominik Monz; Marcus Koch; Andreas Meyerhans; Ludwig Gortner; Claus-Michael Lehr; Hanno Huwer; Alexandra K Kiemer
Journal:  Respir Res       Date:  2010-09-15

9.  The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1.

Authors:  Mao Wang; Samir Gorasiya; Daniel J Antoine; Ravikumar A Sitapara; Wenjun Wu; Lokesh Sharma; Huan Yang; Charles R Ashby; Divya Vasudevan; Michelle Zur; Douglas D Thomas; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

Review 10.  Pattern recognition receptor-dependent mechanisms of acute lung injury.

Authors:  Meng Xiang; Jie Fan
Journal:  Mol Med       Date:  2009-11-02       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.